• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Astrazeneca Plc Ord (OP:AZNCF)

135.22 +1.12 (+0.84%)
Streaming Delayed Price Updated: 2:38 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,394
Open 137.88
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 134.10
Today's Range 135.22 - 137.88
52wk Range 120.64 - 175.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
5 Oversold Stocks to Buy Right Now
September 16, 2024
We've got you covered with a list of oversold stocks to buy right now. Learn more about oversold and overbought stocks on MarketBeat. 
Via MarketBeat
3 stocks that crushed earnings estimates and still tanked
November 20, 2023
Every earnings season, regardless of sector or industry, has its share of stocks that go down even after beating earnings expectations such as these stocks 
Via MarketBeat
Exposures COVID-19

Performance

YTD
+1.0%
+1.0%
1 Month
+4.9%
+4.9%
3 Month
-9.3%
-9.3%
6 Month
+6.6%
+6.6%
1 Year
-13.3%
-13.3%

More News

Read More
AstraZeneca Abandons Blood Cancer, Cardiovascular Programs Amid Portfolio Prioritization
July 28, 2023
Via Benzinga
AstraZeneca Q2 Earnings Beat Consensus Despite Zero COVID-19 Vaccine Sales, Stock Shoots Up
July 28, 2023
Via Benzinga
AstraZeneca-Sanofi's Respiratory Syncytial Virus Treatment Scores FDA Approval To Prevent Infection In Infants
July 18, 2023
Via Benzinga
AstraZeneca Shares Under Pressure On Some Adverse Events In Late-Stage Lung Cancer Drug Trial
July 03, 2023
Via Benzinga
AstraZeneca's Imfinzi/Imjudo Combo Shows Sustained Overall Survival Benefit At Four Years In Liver Cancer
June 29, 2023
Via Benzinga
AstraZeneca Seeks Expanded Use For Soliris As First Targeted Therapy For Pediatric Patients With Autoimmune Neuromuscular Disease
June 26, 2023
Via Benzinga
Why Are Pieris Pharmaceuticals Shares Tanking Today
June 21, 2023
Via Benzinga
AstraZeneca Mulls China Business Unit Spin-Off Amid Geopolitical Tensions
June 20, 2023
Via Benzinga
AstraZeneca's Add On Treatment With Standard Care Improves Hemoglobin Levels In Rare Blood Disorder
June 09, 2023
Via Benzinga
AstraZeneca Inks Over $2B Agreement For Cell Therapies Targeting Diabetes
June 09, 2023
Via Benzinga
Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon
June 09, 2023
Via Benzinga
AstraZeneca's Tagrisso Significantly Enhances Survival in Certain Post Surgery Non-Small Cell Lung Cancer Patients
June 05, 2023
Via Benzinga
AstraZeneca/Merck's Cancer Drug Combo Shows Positive Results In Endometrial Cancer
May 26, 2023
Via Benzinga
AstraZeneca's China Executive Seeks Loyalty to "Love the Communist Party" In China
May 19, 2023
Via Benzinga
One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps
May 17, 2023
Via Benzinga
AstraZeneca' Tagrisso/Chemo Combo Therapy Delays Treatment Resistance, Disease Progression In Certain Type Of Advanced Lung Cancer
May 17, 2023
Via Benzinga
Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody
May 12, 2023
Via Benzinga
FDA Advisory Committee Votes Favoring Restricted Use Of AstraZeneca/Merck's Prostate Cancer Drug
May 01, 2023
Via Benzinga
FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting
April 27, 2023
Via Benzinga
AstraZeneca's COVID-19 Vaccine Loses Shine, Cancer Drug Imfinzi & Emerging Markets Stabilize Q1 Revenues
April 27, 2023
Via Benzinga
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
April 24, 2023
Via Benzinga
Why AstraZeneca Shares Are Trading Higher Today?
April 18, 2023
Via Benzinga
Canadian Cancer Diagnostic Company BioMark Working On Early Lung Detection Assay
April 10, 2023
Via Benzinga

Frequently Asked Questions

Is Astrazeneca Plc Ord publicly traded?
Yes, Astrazeneca Plc Ord is publicly traded.
What exchange does Astrazeneca Plc Ord trade on?
Astrazeneca Plc Ord trades on the OTC Traded
What is the ticker symbol for Astrazeneca Plc Ord?
The ticker symbol for Astrazeneca Plc Ord is AZNCF on the OTC Traded
What is the current price of Astrazeneca Plc Ord?
The current price of Astrazeneca Plc Ord is 135.22
When was Astrazeneca Plc Ord last traded?
The last trade of Astrazeneca Plc Ord was at 05/09/25 02:38 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap